CDK Targets Sae2 to Control DNA-end Resection and Homologous Recombination

Nature - United Kingdom
doi 10.1038/nature07215
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

SAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous Recombination

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

UBQLN4 Promotes Non-Homologous End Joining by Repressing DNA End-Resection

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2019English

DNA Non-Homologous End-Joining Enters the Resection Arena

Oncotarget
Oncology
2017English

DNA Sequence Alignment During Homologous Recombination

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Escape of Sgs1 From Rad9 Inhibition Reduces the Requirement for Sae2 and Functional MRX in DNA End Resection

EMBO Reports
BiochemistryGeneticsMolecular Biology
2015English

Homologous DNA Recombination in Vertebrate Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Mammalian Mitochondria Possess Homologous DNA Recombination Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Regulatory Control of Sgs1 and Dna2 During Eukaryotic DNA End Resection

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

The Purine Scaffold Hsp90 Inhibitor PU-H71 Sensitizes Cancer Cells to Heavy Ion Radiation by Inhibiting DNA Repair by Homologous Recombination and Non-Homologous End Joining

Radiotherapy and Oncology
Nuclear MedicineOncologyRadiologyHematologyImaging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy